Objective: To describe the development, design and function of an innovative international clinical research network for neuroimaging research, based in Australia, within a joint state health service/medical school. This Australian, US, Scandinavian Imaging Exchange (AUSSIE) network focuses upon identifying neuroimaging biomarkers for neuropsychiatric and neurodegenerative disease. Methods: We describe a case study of the iterative development of the network, identifying characteristic features and methods which may serve as potential models for virtual clinical research networks. This network was established to
T he clinical medical researchers in psychiatry and psychiatric neuroscience in Australia who are working in health care settings are generally employed either full-time or part-time in the direct provision of care. To develop high-quality research programs that are funded by external grants schemes generally requires dedicated staffing and time for research which active clinicians lack, especially given that schemes such as the National Health and Medical Research Council are highly competitive. We describe here one model of clinical research that leverages off the skills of researchers, with relatively low infrastructure overheads, largely (but not wholly) in the absence of substantive external grants. We hope our Australian, US, Scandinavian Imaging Exchange (AUSSIE) research network will be a bootstrap to external grant funding ( Figure 1 ).
With the appropriate prospective planning, ethical approval and consent it is possible for clinical researchers to collect useful clinical data during their daily practice, and then combine this with an interest in structural neuroimaging. We have been able to engage a network of collaborative researchers, via a connective hub based within the state Australian Capital Territory Health Service and Australian National University (ANU) Medical School. This type of clinical research has been a tradition within Sweden, where we commenced our collaborations with the Karolinska Institute and Lund University, and also in Australia, at the University of Melbourne, University of South Wales (UNSW) and UWA (University of Western Australia).
In parallel, each of the clinical research centres has differential, complementary expertise in components of the analysis of structural and functional neuroimaging data. Our collaborations with specialist computational neuroscience researchers at University of North Carolina Chapel Hill (UNC), University of California Los Angeles (UCLA) and the University of Southern California (USC) have greatly expanded our scope of research.
Our collaborations are focused around identifying gaps in the literature, specifically with relation to subcortical brain structures, in order to understand the structure-function-symptom relationships, for the development of future biomarkers of disease. We aim to develop clinical biomarkers that may be used as surrogate outcomes in intervention and treatment trials.
Studies were specifically designed to harness the required skills for a mutually planned and written publication, and a virtual project team was created out of the ensemble of skills in our network. The currency of the collaboration is shared publications, access to datasets for the projects and cross-centre skill development.
Methods & Results

Description of the network development
The development of our network was iterative and will be described in detail as a case study, from which we will distil useful principles for other clinical researchers to use when envisaging similar research ( Figure 1 , Table 1 ).
The first collaboration was the development of the interest in the role of the striatum as a structural component in parallel recurrent cortico-striatal circuits subserving cognition, emotion and movement. 1 This was established via design, testing and publication of new methods to manually segment the striatum (caudate and putamen) in magnetic resonance images (MRIs) by our core team at ANU Medical School, in conjunction with UNSW and the Karolinska Institute. 2 This led to measurement of the striatum as a marker of cortico-striatal circuit integrity in post-traumatic stress disorder 3 (PTSD) and fronto-temporal lobar degeneration (FTLD) at the Karolinska Institute, 4 and in post-stroke subjects at the UNSW. 5 Through innovative key collaborators at the Melbourne Neuropsychiatry Centre, Royal Melbourne Hospital (MNC), we were able to use advanced computational neuroscience shape analysis methodologies developed by colleagues at UNC, Chapel Hill. 6 This shape analysis allowed us to more accurately quantify between-group and within-group correlational differences in the shape of striatum in relation to disease or neuropsychiatric disorders with Melbourne Neuropsychiatry Unit on choreacanthocytosis 7 and Karolinska clinical data on FTLD, 4 as well as the hippocampus in FTLD. 8 Access to a larger clinical dataset at MNC of patients with FTLD and related neuropsychiatric disorders led us to explore semi-automated methods 9 for striatal segmentation with collaborators at UCLA, expanding our network and allowing us to upscale projects in collaboration. 10 
Table 1. Establishing a new collaborative network
• Read broadly and consult with research colleagues in and outside your area of research interest;
• Interesting research may involve application of interdisciplinary approaches, or application of established methods in a new field, or gathering together rare datasets; • Identify a research area that is novel and not already heavily researched;
• Develop an area of research expertise: this is essential for participation in any network, and will take time and development from your end; but it is a predicate before any collaboration can exist, as you must have skills to contribute to a collaboration; • Conduct your own research projects in the area towards initial data-based publications framing your interests and displaying your skills; • Identify (via the literature and through your current networks) potential collaborators;
• If possible, ask mutual contacts (of both you and the collaborator) to introduce you to new potential collaborators: that is, leverage your networks to build a trusted introduction; • Meet with your potential collaborators in person initially to discuss a collaborative project: this means you need to meet on your collaborator's turf; • Begin with smaller-scale collaborative projects of mutual interest, to build relationships; • Discuss in detail plans for workflow and writing, for the completion of the project; • Quickly and efficiently produce results from the small project to build trust;
• Write and publish results together with your collaborators; • Use completed projects as a springboard to new projects; • See Table 2 and Table 3 for additional details on project and collaborative management, and be aware of the strengths and pitfalls shown in Table 4 . Together with our key collaborators at Karolinska Institute, we were introduced to clinical researchers at Lund University and Skåne University Hospital in Sweden, where the shape analysis methods could be applied to studies of progressive supra-nuclear palsy. 11 In turn, our collaborators at Lund have worked with us on datasets for persons suffering from FTLD, and further introduced us to other researchers working on pharmacoresistant epilepsy and Parkinson's disease. Through MNC, we applied methods for measurement of mid-sagittal pontine to midbrain ratio to adult Niemann-Pick C disease, uncovering a biomarker associated with clinical eye movement measures in this neurometabolic disorder, 12 and also studied striatal morphology in eating disorders with researchers from Hospital Clinico San Carlos and Complutense University in Madrid.
Through our collaborators at the Karolinska Institute, we were able to access the large European Union (EU) framework of the Leukoaraiosis and Disability in the Elderly study (LADIS) on age-related white matter disease. One of our early career researchers undertook a Master's thesis on this dataset. 13 This published work enabled us to access the entire LADIS study in a new, semi-automated analysis project with USC.
Together with our collaborators at MNC and Monash University, we have a joint PhD student project on subcortical structural morphology in Huntington disease. We also have a senior psychiatry trainee developing a study of Parkinson disease with UWA. We have used methods developed by MNC and UCLA to measure the morphology of the corpus callosum as a biomarker in FTLD.
A new early career collaborator at UWA has joined our network, to develop manual segmentation methods to quantify the shape of the thalamus as a key subcortical hub, and is in turn collaborating through the network with Lund University and with USC, for the shape analysis. This is a snapshot of development to this stage.
Through the Australian hub, we are connecting with and through to our US and Swedish collaborators. Much of our work has focused upon mapping a subcortical connectome 14 with the key subcortical brain structures as potential biomarkers for neurodegenerative disease. This network has resulted in approximately 20 publications in the last 5 years, largely through the goodwill of the clinical and neuroscience researchers involved.
Developing research capacity
Through the hub at the ANU, we have recruited clinical research students, primarily from the graduate medical school program. Medical students at the ANU have a mandatory research project as part of their course requirements; thus, we have hosted more than 20 such students over the last 10 years, as well as students progressing to Masters and Doctoral-level studies.
We have trained collaborative researchers connected via the various research hubs in structural MRI research.
Together with the MNC, we have hosted medical specialist psychiatric researchers from Malaysia and from Spain, and facilitated exchanges.
We have jointly supervised postgraduate research students across all of our centres and plan to expand such co-supervision in the future.
Project planning for our research studies
As we are located in different countries and time zones, our planning is conducted by asynchronous communication Table 2 . The principles of our project planning
• Identifying a dataset of interest;
• Identifying an interesting clinical question that we wish to explore within the dataset;
• Determining the clinical data required (clinical scales, neuropsychology, demographics and neuroimaging);
• Assembling the relevant collaborators from the network;
• Agreeing on a draft project plan, including publication and encompassing authorship, project leads, relevant roles, timelines and outcomes (papers); • Seeking ethical approval at origin data site, and at each involved site locally, before commencement; • Sharing only de-identified imaging and clinical data (original data site de-identifies data, using an anonymised unique ID number for each subject, for whom only the origin has the key) for analysis; • Sharing processed imaging and clinical data analysed, as per agreement with the origin site and other collaborators;
• Coordinating via the central hub at ANU Medical School/ACT Health Directorate of network projects, and logistics support from the hub for each centre's self-run projects needing access to the network; • Recruiting mutually supervised clinical researchers for postgraduate degrees, based upon the research projects (Masters, PhD).
ACT: Australian Capital Territory; ANU: Australian National University; ID: identification; PhD: doctoral degree (Doctor of Philosophy) via email, supplemented by phone calls and yearly face-toface meetings with the network coordinator ( Table 2 ).
Discussion
We have described an outline of the iterative development of a synergistic virtual clinical research network running on the proverbial smell of an oily rag through the generous and essential contribution of expertise, work and infrastructure from each centre. As such, we have achieved collaboratively more than we could if we sought to develop, in each centre, the same level of expertise in our own research specialities, and expanded our contacts for sharing and developing clinical research ideas. Virtual research networks like ours can be a springboard to launch and train clinicians and neuroscience researchers in clinical research towards practical research literacy, as well as enhancing capacity for such research in healthcare settings. As the Australian hubs of the network are embedded within a shared public health and university setting, we are an example of a virtual • Early discussion of a project, the participants and publication authorship details are very important;
• Memoranda of understanding between collaborators can provide a vehicle through which to discuss such issues;
• Choose collaborators to join the network who are informed by those already within the network. Bringing together a variety of skills and interests:
• Neuroimaging work requires different skill sets, from the skill required to manually trace images, through to the higherlevel mathematical and computational skills required to develop semi-automated or automatic algorithms; • Collaborations may develop from complementary skill sets.
Having shared interests in clinical research:
• Collaborators must share research ideas and interests, whilst being flexible enough to accommodate alternative views. Importance of coordination, logistics and good communication:
• Face to face communication is the ideal;
• Good communication can still occur through other media, as long as care is taken with the logistics and technology.
integrated health research network, and describe some of our principles of development in Table 3 . Similarly, much larger-scale virtual research networks developed for genetic neuroimaging analysis, such as the ENIGMA consortium, also exist. 15 In the international development context, similar virtual networks, such as Crisis Mapping, a voluntary, self-assembling association sharing data and computational methodology that collaborates with local embedded partners to map evolving world crises (disasters and conflicts), also exist. 16 As with any developmental collaboration, there are strengths and pitfalls of the model, which we describe in Table 4 .
The next stage in our network development will be necessarily to seek innovative ongoing funding to support our projects across and via our respective centres, towards expansion of the network to the Asia-Pacific region and further centres.
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